A share price of Teladoc Health Inc [TDOC] is currently trading at $9.04, up 4.15%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TDOC shares have gain 6.86% over the last week, with a monthly amount glided 17.86%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Teladoc Health Inc [NYSE: TDOC] stock has seen the most recent analyst activity on September 17, 2024, when Jefferies reiterated its Hold rating and also boosted its price target to $10 from $8. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on February 29, 2024, and set its price target to $22. On February 26, 2024, Leerink Partners initiated with a Market Perform rating and assigned a price target of $17 on the stock. DA Davidson downgraded its rating to a Neutral and decreased its price target to $22 on January 17, 2024. Barclays initiated its recommendation with a Overweight and recommended $26 as its price target on January 03, 2024. Stephens started tracking with a Equal-Weight rating for this stock on April 12, 2023, and assigned it a price target of $25. In a note dated February 23, 2023, SVB Securities upgraded an Outperform rating on this stock but restated the target price of $34.
Teladoc Health Inc experienced fluctuations in its stock price throughout the past year between $6.76 and $22.54. Currently, Wall Street analysts expect the stock to reach $52.65 within the next 12 months. Teladoc Health Inc [NYSE: TDOC] shares were valued at $9.04 at the most recent close of the market. An investor can expect a potential return of 482.41% based on the average TDOC price forecast.
Analyzing the TDOC fundamentals
Trailing Twelve Months sales for Teladoc Health Inc [NYSE:TDOC] were 2.61B which represents -1.53% decline. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.11%, Pretax Profit Margin comes in at -0.38%, and Net Profit Margin reading is -0.39%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.48 and Total Capital is -0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.82 points at the first support level, and at 8.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.16, and for the 2nd resistance point, it is at 9.28.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Teladoc Health Inc [NYSE:TDOC] is 1.62. Further, the Quick Ratio stands at 1.59, while the Cash Ratio is 1.25. Considering the valuation of this stock, the price to sales ratio is 0.59, the price to book ratio is 1.03.
Transactions by insiders
Recent insider trading involved Bliss Kelly, President, U.S. Group Health, that happened on Oct 02 ’24 when 897.0 shares were sold. Officer, Nanis Nikolaos P. completed a deal on Oct 02 ’24 to buy 454.0 shares. Meanwhile, Officer Bliss Kelly bought 897.0 shares on Oct 02 ’24.
